JP2023551194A5 - - Google Patents
Info
- Publication number
- JP2023551194A5 JP2023551194A5 JP2023530548A JP2023530548A JP2023551194A5 JP 2023551194 A5 JP2023551194 A5 JP 2023551194A5 JP 2023530548 A JP2023530548 A JP 2023530548A JP 2023530548 A JP2023530548 A JP 2023530548A JP 2023551194 A5 JP2023551194 A5 JP 2023551194A5
- Authority
- JP
- Japan
- Prior art keywords
- substitution
- modified igg
- section
- igg
- modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063116491P | 2020-11-20 | 2020-11-20 | |
| US63/116,491 | 2020-11-20 | ||
| PCT/US2021/060161 WO2022109313A1 (en) | 2020-11-20 | 2021-11-19 | Bovine antibody variants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023551194A JP2023551194A (ja) | 2023-12-07 |
| JP2023551194A5 true JP2023551194A5 (https=) | 2024-11-07 |
Family
ID=79018979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530548A Pending JP2023551194A (ja) | 2020-11-20 | 2021-11-19 | ウシ科動物抗体バリアント |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230416410A1 (https=) |
| EP (1) | EP4247851A1 (https=) |
| JP (1) | JP2023551194A (https=) |
| KR (1) | KR20230110297A (https=) |
| CN (1) | CN116615463A (https=) |
| AR (1) | AR124130A1 (https=) |
| AU (1) | AU2021382704A1 (https=) |
| BR (1) | BR112023008490A2 (https=) |
| CA (1) | CA3202089A1 (https=) |
| CO (1) | CO2023007146A2 (https=) |
| MX (1) | MX2023005896A (https=) |
| WO (1) | WO2022109313A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4255933A4 (en) | 2020-12-07 | 2025-07-23 | Invetx Inc | COMPOSITIONS FOR INCREASING THE HALF-LIFE OF A THERAPEUTIC AGENT IN LIVESTOCK ANIMALS AND METHODS OF USE |
| CN119730881A (zh) * | 2022-08-05 | 2025-03-28 | 硕腾服务有限责任公司 | 牛抗体突变体 |
| JP2025529206A (ja) * | 2022-09-02 | 2025-09-04 | ゾエティス・サービシーズ・エルエルシー | 豚抗体変異体 |
| CN119735654B (zh) * | 2025-02-27 | 2025-07-01 | 浙江海隆生物科技股份有限公司 | 一种牛副流感病毒的亚单位hn蛋白制备方法和应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| US5698762A (en) | 1994-12-09 | 1997-12-16 | Dauerman; Leonard | Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons |
| US20030031671A1 (en) | 2001-08-01 | 2003-02-13 | Sydney Welt | Methods of treating colon cancer utilizing tumor-specific antibodies |
| AU2005285347A1 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| AU2005304624B2 (en) | 2004-11-12 | 2010-10-07 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| ES2984405T3 (es) * | 2012-09-13 | 2024-10-29 | Bristol Myers Squibb Co | Proteínas de dominio de andamio basadas en fibronectina que se unen a la miostatina |
| US11891440B2 (en) * | 2015-10-05 | 2024-02-06 | Circle33 Llc | Antibodies with improved stability to intestinal digestion, polynucleotides thereof and methods of use thereof to treat disease |
-
2021
- 2021-11-19 JP JP2023530548A patent/JP2023551194A/ja active Pending
- 2021-11-19 WO PCT/US2021/060161 patent/WO2022109313A1/en not_active Ceased
- 2021-11-19 US US18/037,514 patent/US20230416410A1/en active Pending
- 2021-11-19 KR KR1020237020005A patent/KR20230110297A/ko active Pending
- 2021-11-19 CA CA3202089A patent/CA3202089A1/en active Pending
- 2021-11-19 CN CN202180081802.8A patent/CN116615463A/zh active Pending
- 2021-11-19 MX MX2023005896A patent/MX2023005896A/es unknown
- 2021-11-19 EP EP21830362.6A patent/EP4247851A1/en active Pending
- 2021-11-19 BR BR112023008490A patent/BR112023008490A2/pt unknown
- 2021-11-19 AU AU2021382704A patent/AU2021382704A1/en active Pending
- 2021-11-23 AR ARP210103234A patent/AR124130A1/es unknown
-
2023
- 2023-05-30 CO CONC2023/0007146A patent/CO2023007146A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023551194A5 (https=) | ||
| KR102855748B1 (ko) | Sirp-알파 도메인 또는 이의 변이체를 갖는 구조체 | |
| AU2022206732A1 (en) | Antibodies binding to CD3 | |
| TWI832824B (zh) | 自單特異性抗體於活體內產生多特異性抗體之方法 | |
| JP7736688B2 (ja) | 多重特異性抗原結合分子を製造するための方法 | |
| RU2016139006A (ru) | Мультимерные fc-белки | |
| RU2016139022A (ru) | МУЛЬТИМЕРНЫЕ Fc-БЕЛКИ | |
| CN118206639A (zh) | 与经改造的Fc构建体相关的组合物和方法 | |
| JP2021500348A (ja) | 単一特異性抗体から多重特異性抗体を生成させるための方法 | |
| JP2023522029A5 (https=) | ||
| WO2023186120A1 (zh) | 抗血清白蛋白纳米抗体及其衍生物 | |
| CA3092387A1 (en) | Anti-trem-1 antibodies and uses thereof | |
| WO2022081794A1 (en) | Shielded biologics with masking domains to shield antigen binding capability of biologics and uses thereof | |
| TW202144431A (zh) | 工程化抗her2雙特異性蛋白 | |
| JP7657591B2 (ja) | 二重特異性抗原結合コンストラクト | |
| CA3096791A1 (en) | Cell engaging binding molecules | |
| CN121057750A (zh) | 结合ox40l的抗体和使用方法 | |
| IL298921A (en) | Antibodies which bind to cancer cells and target radionuclides to said cells | |
| JP2025528213A (ja) | 複数ドメイン結合性分子 | |
| CN115151567A (zh) | 治疗性Fc组合物的化学诱导结合和解离以及T细胞接合器与人血清白蛋白的化学诱导二聚化 | |
| WO2019178539A1 (en) | Bispecific antibodies | |
| US20210253741A1 (en) | Bispecific antibodies | |
| CN115551538A (zh) | 干扰IL-1β受体信号转导的药剂 | |
| TW202146463A (zh) | 蛋白酶加工的分子 | |
| RU2025102187A (ru) | Мутанты бычьих антител |